848 related articles for article (PubMed ID: 28778318)
1. Dendritic cell-targeted porcine reproductive and respiratory syndrome virus (PRRSV) antigens adjuvanted with polyinosinic-polycytidylic acid (poly (I:C)) induced non-protective immune responses against heterologous type 2 PRRSV challenge in pigs.
Subramaniam S; Piñeyro P; Derscheid RJ; Madson DM; Magstadt DR; Meng XJ
Vet Immunol Immunopathol; 2017 Aug; 190():18-25. PubMed ID: 28778318
[TBL] [Abstract][Full Text] [Related]
2. Recombinant Porcine Reproductive and Respiratory Syndrome Virus Expressing Membrane-Bound Interleukin-15 as an Immunomodulatory Adjuvant Enhances NK and γδ T Cell Responses and Confers Heterologous Protection.
Cao QM; Ni YY; Cao D; Tian D; Yugo DM; Heffron CL; Overend C; Subramaniam S; Rogers AJ; Catanzaro N; LeRoith T; Roberts PC; Meng XJ
J Virol; 2018 Jul; 92(13):. PubMed ID: 29643245
[TBL] [Abstract][Full Text] [Related]
3. In vivo targeting of porcine reproductive and respiratory syndrome virus antigen through porcine DC-SIGN to dendritic cells elicits antigen-specific CD4T cell immunity in pigs.
Subramaniam S; Piñeyro P; Tian D; Overend C; Yugo DM; Matzinger SR; Rogers AJ; Haac ME; Cao Q; Heffron CL; Catanzaro N; Kenney SP; Huang YW; Opriessnig T; Meng XJ
Vaccine; 2014 Nov; 32(50):6768-75. PubMed ID: 25446829
[TBL] [Abstract][Full Text] [Related]
4. Immune responses and protection by vaccine and various vaccine adjuvant candidates to virulent porcine reproductive and respiratory syndrome virus.
Charerntantanakul W; Platt R; Johnson W; Roof M; Vaughn E; Roth JA
Vet Immunol Immunopathol; 2006 Jan; 109(1-2):99-115. PubMed ID: 16165219
[TBL] [Abstract][Full Text] [Related]
5. HSP70 fused with GP3 and GP5 of porcine reproductive and respiratory syndrome virus enhanced the immune responses and protective efficacy against virulent PRRSV challenge in pigs.
Li J; Jiang P; Li Y; Wang X; Cao J; Wang X; Zeshan B
Vaccine; 2009 Feb; 27(6):825-32. PubMed ID: 19070639
[TBL] [Abstract][Full Text] [Related]
6. Efficacy of a modified live porcine reproductive and respiratory syndrome virus (PRRSV) vaccine in pigs naturally exposed to a heterologous European (Italian cluster) field strain: Clinical protection and cell-mediated immunity.
Martelli P; Gozio S; Ferrari L; Rosina S; De Angelis E; Quintavalla C; Bottarelli E; Borghetti P
Vaccine; 2009 Jun; 27(28):3788-99. PubMed ID: 19442420
[TBL] [Abstract][Full Text] [Related]
7. Comparison of Two Commercial Type 1 Porcine Reproductive and Respiratory Syndrome Virus (PRRSV) Modified Live Vaccines against Heterologous Type 1 and Type 2 PRRSV Challenge in Growing Pigs.
Kim T; Park C; Choi K; Jeong J; Kang I; Park SJ; Chae C
Clin Vaccine Immunol; 2015 Jun; 22(6):631-40. PubMed ID: 25855554
[TBL] [Abstract][Full Text] [Related]
8. Virus replicon particles expressing porcine reproductive and respiratory syndrome virus proteins elicit immune priming but do not confer protection from viremia in pigs.
Eck M; Durán MG; Ricklin ME; Locher S; Sarraseca J; Rodríguez MJ; McCullough KC; Summerfield A; Zimmer G; Ruggli N
Vet Res; 2016 Feb; 47():33. PubMed ID: 26895704
[TBL] [Abstract][Full Text] [Related]
9. Enhanced immune responses in pigs by DNA vaccine coexpressing GP3 and GP5 of European type porcine reproductive and respiratory syndrome virus.
Ren J; Lu H; Wen S; Sun W; Yan F; Chen X; Jing J; Liu H; Liu C; Xue F; Xiao P; Xin S; Jin N
J Virol Methods; 2014 Sep; 206():27-37. PubMed ID: 24882496
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of the efficacy of a new modified live porcine reproductive and respiratory syndrome virus (PRRSV) vaccine (Fostera PRRS) against heterologous PRRSV challenge.
Park C; Seo HW; Han K; Kang I; Chae C
Vet Microbiol; 2014 Aug; 172(3-4):432-42. PubMed ID: 24970363
[TBL] [Abstract][Full Text] [Related]
11. Cross-protection of a new type 2 porcine reproductive and respiratory syndrome virus (PRRSV) modified live vaccine (Fostera PRRS) against heterologous type 1 PRRSV challenge in growing pigs.
Park C; Choi K; Jeong J; Chae C
Vet Microbiol; 2015 May; 177(1-2):87-94. PubMed ID: 25769646
[TBL] [Abstract][Full Text] [Related]
12. Cell-mediated immune response and protective efficacy of porcine reproductive and respiratory syndrome virus modified-live vaccines against co-challenge with PRRSV-1 and PRRSV-2.
Madapong A; Saeng-Chuto K; Boonsoongnern A; Tantituvanont A; Nilubol D
Sci Rep; 2020 Feb; 10(1):1649. PubMed ID: 32015495
[TBL] [Abstract][Full Text] [Related]
13. Plasmid containing CpG oligodeoxynucleotides can augment the immune responses of pigs immunized with porcine reproductive and respiratory syndrome killed virus vaccine.
Quan Z; Qin ZG; Zhen W; Feng XZ; Hong J; Fei ZH
Vet Immunol Immunopathol; 2010 Aug; 136(3-4):257-64. PubMed ID: 20394988
[TBL] [Abstract][Full Text] [Related]
14. Immune responses of pigs immunized with a recombinant porcine reproductive and respiratory syndrome virus expressing porcine GM-CSF.
Li Z; Wang G; Wang Y; Zhang C; Huang B; Li Q; Li L; Xue B; Ding P; Cai X; Wang C; Zhou EM
Vet Immunol Immunopathol; 2015 Nov; 168(1-2):40-8. PubMed ID: 26300317
[TBL] [Abstract][Full Text] [Related]
15. A porcine reproductive and respiratory syndrome virus candidate vaccine based on the synthetic attenuated virus engineering approach is attenuated and effective in protecting against homologous virus challenge.
Evenson D; Gerber PF; Xiao CT; Halbur PG; Wang C; Tian D; Ni YY; Meng XJ; Opriessnig T
Vaccine; 2016 Nov; 34(46):5546-5553. PubMed ID: 27742217
[TBL] [Abstract][Full Text] [Related]
16. Intranasal immunization of pigs with porcine reproductive and respiratory syndrome virus-like particles plus 2', 3'-cGAMP VacciGrade™ adjuvant exacerbates viremia after virus challenge.
Van Noort A; Nelsen A; Pillatzki AE; Diel DG; Li F; Nelson E; Wang X
Virol J; 2017 Apr; 14(1):76. PubMed ID: 28403874
[TBL] [Abstract][Full Text] [Related]
17. Cross-protective immunity to porcine reproductive and respiratory syndrome virus by intranasal delivery of a live virus vaccine with a potent adjuvant.
Dwivedi V; Manickam C; Patterson R; Dodson K; Murtaugh M; Torrelles JB; Schlesinger LS; Renukaradhya GJ
Vaccine; 2011 May; 29(23):4058-66. PubMed ID: 21419162
[TBL] [Abstract][Full Text] [Related]
18. Commercial porcine reproductive and respiratory syndrome virus (PRRSV)-2 modified live virus vaccine against heterologous single and dual Korean PRRSV-1 and PRRSV-2 challenge.
Jeong J; Kim S; Park C; Park KH; Kang I; Park SJ; Chae C
Vet Rec; 2018 Apr; 182(17):485. PubMed ID: 29472439
[TBL] [Abstract][Full Text] [Related]
19. Development of a porcine reproductive and respiratory syndrome virus-like-particle-based vaccine and evaluation of its immunogenicity in pigs.
Binjawadagi B; Lakshmanappa YS; Longchao Z; Dhakal S; Hiremath J; Ouyang K; Shyu DL; Arcos J; Pengcheng S; Gilbertie A; Zuckermann F; Torrelles JB; Jackwood D; Fang Y; Renukaradhya GJ
Arch Virol; 2016 Jun; 161(6):1579-89. PubMed ID: 27008569
[TBL] [Abstract][Full Text] [Related]
20. Comparison of two genetically distant type 2 porcine reproductive and respiratory syndrome virus (PRRSV) modified live vaccines against Vietnamese highly pathogenic PRRSV.
Do DT; Park C; Choi K; Jeong J; Nguyen TT; Nguyen KD; Vo DT; Chae C
Vet Microbiol; 2015 Sep; 179(3-4):233-41. PubMed ID: 26149103
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
